Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LTA4H | P09960 | 1/20 | 0.40 |
| ▸ | CA12 | O43570 | 1/20 | 0.39 |
| ▸ | CA1 | P00915 | 1/20 | 0.39 |
| ▸ | CA2 | P00918 | 1/20 | 0.39 |
| ▸ | CA9 | Q16790 | 1/20 | 0.39 |
| ▸ | DRD3 | P35462 | 8/20 | 0.37 |
| ▸ | DRD2 | P14416 | 8/20 | 0.37 |
| ▸ | SLC6A4 | P31645 | 2/20 | 0.36 |
| ▸ | HRH3 | Q9Y5N1 | 2/20 | 0.36 |
| ▸ | SLC6A2 | P23975 | 1/20 | 0.36 |
| ▸ | SLC6A3 | Q01959 | 1/20 | 0.36 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.35 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.35 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.35 |
| ▸ | CYP2D6 | P10635 | 2/20 | 0.35 |
| ▸ | CYP2C19 | P33261 | 2/20 | 0.35 |
| ▸ | OPRM1 | P35372 | 2/20 | 0.35 |
| ▸ | DRD4 | P21917 | 2/20 | 0.35 |
| ▸ | TP53 | P04637 | 1/20 | 0.35 |
| ▸ | TSHR | P16473 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL18959040 | 1.00 | LTA4H (0.40) | LTA4HCA12CA1CA2CA9 | |
| SCHEMBL18959038 | 1.00 | LTA4H (0.40) | LTA4HCA12CA1CA2CA9 | |
| SCHEMBL11929530 | 0.88 | HRH3 (0.37) | LTA4HCA12CA1CA2CA9 | |
| SCHEMBL22282207 | 0.88 | HRH3 (0.37) | LTA4HCA12CA1CA2CA9 | |
| SCHEMBL21375222 | 0.88 | HRH3 (0.37) | LTA4HCA12CA1CA2CA9 | |
| SCHEMBL6833198 | 0.85 | EBP (0.41) | SLC6A4HRH3 | |
| SCHEMBL27946481 | 0.85 | EBP (0.41) | SLC6A4HRH3 | |
| SCHEMBL9276365 | 0.83 | — | — | |
| SCHEMBL13180183 | 0.83 | — | — | |
| SCHEMBL12312341 | 0.83 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 40 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3227234-B1 | SILICOALUMINOPHOSPHATE MOLECULAR SIEVES USING AN ORGANO-1-OXA-4-AZONIUMCYCLOHEXANE COMPOUND | UOP LLC (US) | 2021-05-26 | — | — | EP | claimed |
| US-20180258058-A1 | ORGANO-1-OXA-4-AZONIUM CYCLOHEXANE COMPOUNDS | UOP LLC (US) | 2018-09-13 | — | — | US | claimed |
| US-9815706-B2 | Zeolites using an organo-1-oxa-4-azoniumcyclohexane compound | UOP LLC (US) | 2017-11-14 | — | — | US | claimed |
| EP-3227266-A2 | ORGANO-1-OXA-4-AZONIUM CYCLOHEXANE COMPOUNDS | UOP LLC (US) | 2017-10-11 | — | — | EP | claimed |
| US-9751772-B2 | Aluminophosphate molecular sieves using an organo-1-oxa-4-azoniumcyclohexane compound | UOP LLC (US) | 2017-09-05 | — | — | US | claimed |
| US-20170044120-A1 | ORGANO-1-OXA-4-AZONIUM CYCLOHEXANE COMPOUNDS | UOP LLC (US) | 2017-02-16 | — | — | US | claimed |
| US-9522896-B2 | Organo-1-oxa-4-azonium cyclohexane compounds | UOP LLC (US) | 2016-12-20 | — | — | US | claimed |
| US-20160159760-A1 | ORGANO-1-OXA-4-AZONIUM CYCLOHEXANE COMPOUNDS | UOP LLC | 2016-06-09 | — | — | US | claimed |
| US-20160159656-A1 | ALUMINOPHOSPHATE MOLECULAR SIEVES USING AN ORGANO-1-OXA-4-AZONIUMCYCLOHEXANE COMPOUND | UOP LLC | 2016-06-09 | — | — | US | claimed |
| US-20160159655-A1 | ZEOLITES USING AN ORGANO-1-OXA-4-AZONIUMCYCLOHEXANE COMPOUND | UOP LLC | 2016-06-09 | — | — | US | claimed |
| WO-2024081311-A1 | CBL-B MODULATORS AND USES THEREOF | NIMBUS CLIO, INC. (US) | 2024-04-18 | — | — | WO | disclosed |
| WO-2023230190-A1 | PYRIMIDINE BASED MODULATORS AND USES THEREOF | QUANTA THERAPEUTICS, INC. (US) | 2023-11-30 | — | — | WO | disclosed |
| WO-2023066292-A1 | TRICYCLIC BORONIC ACID DERIVATIVE, AND PREPARATION METHOD THEREFOR AND APPLICATION THEREOF | 上海济煜医药科技有限公司 | 2023-04-27 | — | — | WO | disclosed |
| WO-2021226458-A1 | AKT3 MODULATORS | GEORGIAMUNE LLC (US) | 2021-11-11 | — | — | WO | disclosed |
| EP-3227234-B1 | SILICOALUMINOPHOSPHATE MOLECULAR SIEVES USING AN ORGANO-1-OXA-4-AZONIUMCYCLOHEXANE COMPOUND | UOP LLC (US) | 2021-05-26 | — | — | EP | disclosed |
| US-20160159760-A1 | ORGANO-1-OXA-4-AZONIUM CYCLOHEXANE COMPOUNDS | UOP LLC | 2016-06-09 | — | — | US | disclosed |
| US-20160159656-A1 | ALUMINOPHOSPHATE MOLECULAR SIEVES USING AN ORGANO-1-OXA-4-AZONIUMCYCLOHEXANE COMPOUND | UOP LLC | 2016-06-09 | — | — | US | disclosed |
| US-20160159655-A1 | ZEOLITES USING AN ORGANO-1-OXA-4-AZONIUMCYCLOHEXANE COMPOUND | UOP LLC | 2016-06-09 | — | — | US | disclosed |
| US-20140288068-A1 | ALKYL-AMINE HARMINE DERIVATIVES FOR PROMOTING BONE GROWTH | OSSIFI INC. (US) | 2014-09-25 | — | — | US | disclosed |
| US-4992150-A | Telomer with alpha-olefin;oil and fuel additive | NIPPON OIL CO, LTD. (JP) | 1991-02-12 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20160159760-A1 | ORGANO-1-OXA-4-AZONIUM CYCLOHEXANE COMPOUNDS | OXSR1, OXER1, OCIAD1 | LTA4H 1023/4885CA12 1579/4885CA1 181/4885 |
| US-20140288068-A1 | ALKYL-AMINE HARMINE DERIVATIVES FOR PROMOTING BONE GROWTH | TPH1, TPH2, HTR5A | LTA4H 3399/4885CA12 3813/4885CA1 4082/4885 |
| US-20180258058-A1 | ORGANO-1-OXA-4-AZONIUM CYCLOHEXANE COMPOUNDS | OXSR1, OXER1, OCIAD1 | LTA4H 1023/4885CA12 1579/4885CA1 181/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.